Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2000-11-07
2009-12-01
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C554S079000
Reexamination Certificate
active
07625883
ABSTRACT:
Optionally O-substituted glycero-phosphoinositol derivatives, their analogues and their salts wherein the substitutents: R′1, R′2, R2, R3, R4, R5, R6 have the described meaning, their synthesis and their pharmacological effect as modulators of the activation or over-stimulation of cPLA2.
REFERENCES:
patent: 0 100 499 (1984-02-01), None
patent: 0 496 474 (1992-07-01), None
patent: 2 517 310 (1983-06-01), None
patent: WO 91 06301 (1991-05-01), None
patent: WO 91/12256 (1991-08-01), None
patent: WO 95 05479 (1995-02-01), None
patent: WO 97/48381 (1997-12-01), None
Young et al. “Total Synthesis of the Four Stereoisomers of Dihexadecanoyl Phophatidylinositol and the Substrate Stereospecificity of Human Erythrocyte Membrane Phosphatidylinositol 4-Kinase” J. Med. Chem. 1990, vol. 33, pp. 641-646.
Burke et al. “Cooperativity and Binding in the Mechanism of Cytosolic Phospholipase A2” Biochemistry, 1995, vol. 34, pp. 15165-15174.
Berrie, C.P. et al, “Membrane transport and in vitro metabolism of the Ras cascade messenger, glycerophosphoinositol 4-phosphate” European Journal of Biochemistry, vol. 266, No. 2, Dec. 1999 pp. 413-419, XP001011370.
Brown, D.M. et al., “Phospholipids. Part V. The Hydrolysis of Glycerol 1-esters of myoinositol 1- and 2- Phosphate,” Journal of The Chemical Society, Nov. 1959, pp. 3547-3552, XP002171609.
Chemical Abstracts, vol. 075, No. 13, Sep. 27, 1971, Columbus, OH, US; abstract No. 088863, Klyashchitskii B. A. et al, Klyashchitskii B. A. et al., “Derivatives of asymmetrically substituted myoinositol. VI., Synthesis of 2, 3, 4, 5, 6- and 1, 2, 4, 5, 6-penta-O-benzyl-sn-glyceryl-phosphoryl)-sn-myo-inositol” XP002171809.
Corda D. et al., “Glycerophosphoinositols as potential markers of Ras-induced transformation and novel second messengers,” Anticancer Research, vol. 16, No. 3B, May 1996, pp. 1341-1350, XP001011369.
Morisaki, N. et al., “Phosphorylation of Unnatural Phosphatidylinositols with Phosphatidylinositol 3-Kinase” Tetrahedron, NL, Elsevier Science Publishers, Amsterdam, vol. 56, No. 17, Apr. 2000, pp. 2603-2614, XP0041974757.
Shirai, R. et al., “The Structural requirement of Phosphatidylinositols as substrate of Phosphatidylinositol 3- Kinase,” Tetrahedron Letters, NL, Elsevier Science Publishers, Amsterdam, vol. 40, No. 9, Feb. 26, 1999, pp. 1693-1696, XP004157168.
Shvets V.I. et al., “Rosolution of Asymmetrically Substituted Myoinositols into Optical Antipodes,” Tetrahedron., vol. 29, No. 2, 1973, pp. 331-340, XP002171610.
Young, R.C. et al., “Total synthesis of the four stereoisomers of dihexadecanoyl phosphatidylinositol and the substrate stereospecificity of human erythrocyte membrane phosphatidylinositol 4-kinase,” Journal of Medicinal Chemistry, vol. 33, No. 2, Feb. 1990 pp. 641-646, XP002171611.
Armandi-Burgermeister, E., et al. Suppression of cytokine synthesis integrin expression and chronic inflammation by inhibitors of cytosolic phospholipase A2, European Journal of Pharmocology, May 20, 1997, pp. 237-250, vol. 326, Elsevier Science B.V.
Berrie, C.P., et al., “Glycerophosphoinositol-4-phosphate in intracellular signalling” inBioactive Lipids, Vanderbock, Y.Y.. ed., 1998, pp. 229-237 Plenum Publishing.
Bonvento Giovanna
Corda Daniela
Dal Monte Renzo
Dal Toso Roberto
Marcolongo Gabriele
Anderson Rebecca L
I.R.B. Istituto di Ricerche Biotechnologiche S.R.L.
Kalow & Springut LLP
Kosack Joseph R
LandOfFree
Glycerophosphoinositol derivatives as modulators of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycerophosphoinositol derivatives as modulators of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycerophosphoinositol derivatives as modulators of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4057293